A novel grading approach predicts worse outcomes in stage pT1 non-muscle-invasive bladder cancer (2024) Haas M, Engelmann SU, Mayr R, Gossler C, Pickl C, Kälble S, Yang Y, et al. Journal article Prognostic impact of variant histologies in urothelial bladder cancer treated with radical cystectomy (2023) Claps F, van de Kamp MW, Mayr R, Bostrom PJ, Shariat SF, Hippe K, Bertz S, et al. Journal article Transurethral en bloc submucosal hydrodissection vs conventional resection for resection of non-muscle-invasive bladder cancer (HYBRIDBLUE): a randomised, multicentre trial (2020) Gakis G, Karl A, Bertz S, Burger M, Fritsche HM, Hartmann A, Jokisch F, et al. Journal article FOXM1 overexpression is associated with adverse outcome and predicts response to intravesical instillation therapy in stage pT1 non-muscle-invasive bladder cancer (2019) Breyer J, Wirtz RM, Erben P, Rinaldetti S, Worst TS, Stoehr R, Eckstein M, et al. Journal article The World Health Organization 1973 classification system for grade is an important prognosticator in T1 non-muscle-invasive bladder cancer (2018) van de Putte EE, Bosschieter J, van der Kwast TH, Bertz S, Denzinger S, Manach Q, Compérat EM, et al. Journal article Non-steroidal antiandrogen monotherapy compared with luteinizing hormone-releasing hormone agonists or surgical castration monotherapy for advanced prostate cancer: a Cochrane systematic review (2015) Kunath F, Grobe HR, Ruecker G, Motschall E, Antes G, Dahm P, Wullich B, Meerpohl JJ Journal article